EQT nabs secondaries firm Coller Capital for $3.2bn; Carlyle’s Robert Schmidt points to open IPO window following Medline listing

Good morning, Hubsters. Senior reporter Michael Schoeck here with the US edition of the Wire from the New York newsroom.

First up today is a fresh deal announced earlier this morning, with EQT making a splash in the secondaries market buying Coller Capital, regarded as one of the first secondaries investors.